Singapore expands longevity clinics and research amid rapid population aging
Source: FRANCE 24 English · All FRANCE 24 English reports
Unlock the full scoreboard
Letter grade, factuality, lean, and rationales — free with registration. No card required.
See grades free How grading works
Already have an account? Sign in. The full report below is free to read.
Disagree with this grade or political lean?
Flagging is open to every reader with a free account. Sign in or create one to dispute this report.
Topics in this report
Summary
The FRANCE 24 segment explores Singapore's response to one of the world's fastest-aging populations through senior parkour classes (800+ participants), personalized longevity clinics using AI-analyzed biomarkers and health coaching, and government-funded research at NUS on slowing brain aging. It features interviews with participants from age 31 to 83, clinic clients, Dr. Hisham Badaruddin, and Professor Vincenzo Sorrentino, who links healthy elderly to economic needs given low fertility. The report notes double-digit growth in the longevity sector and Singapore's near-84-year life expectancy, ranking it among the world's top 10 longest-living nations.
Sourcing relies on on-the-ground interviews, clinic demonstrations, and expert commentary rather than named official statistics or documents; graphics are minimal, with throughlines emphasizing prevention, personalization, and shifting from treatment to proactive health across all ages.
Editorial Assessment
The segment is informative and visually engaging, accurately portraying Singapore's proactive stance on aging with real examples of senior fitness programs, supplement-tracking young adults, and high-end clinics (S$2,800–12,000/year). Claims on demographics and research hold up well against official 2026 Population in Brief data and NUS programs. Viewers may miss the gap between life expectancy (~83.9 years in 2025) and healthy life expectancy (about 11 years in poor health), plus that premium clinics primarily serve affluent clients while public efforts like Age Well SG focus on broader accessibility. The optimistic tone on future democratization (comparing to early cars) downplays current high costs and limited long-term evidence for many interventions. Overall quality is high for a short feature, though it could have included more counterpoints on hype vs. proven outcomes in longevity medicine.
Key Moments
In 2010, one in 10 Singaporeans was over 65; by 2030, more than one in four
Close but slightly high for 2010 (~9% of residents per SingStat); 2030 projection of ~24% aligns with NPTD estimates of over 1-in-4 by 2035.
Singapore's fertility rate has fallen to around one child per woman, one of the lowest in the world
Resident TFR was 0.87 in 2025 per Population in Brief 2026, among the world's lowest.
Longevity industry expanding rapidly with double-digit growth in recent years
Wellness/longevity economy grew significantly (e.g., from $15B in 2021 to $23.2B in 2024); quantified recent annual growth ~8.2%, consistent with double-digit in earlier recovery years.
Singapore life expectancy of almost 84 years, among world's 10 longest-living countries
Resident life expectancy reached 83.9 years in 2025; consistently ranks top 10 globally.
Clinics analyze over 170 biomarkers with AI (vs. ~30 in standard test)
Confirmed at TSquared Health / clinics led by Dr. Hisham Badaruddin, matching the segment's description.
Notable Concerns
- Minor overstatement of 2010 elderly share (one in 10 vs. official ~9%)
- Longevity industry described as recording double-digit growth; recent quantified growth was 8.2% (2023-2024)
- Limited discussion of evidence base or risks for expensive biomarker/AI interventions
Sources Consulted
- Population in Brief 2026
- Singapore now a 'super-aged' society, with more than 1 in 5 citizens aged 65 and above
- Life expectancy of Singapore residents rises to 83.9 years in 2025
- Singapore’s fertility rate drops to historic low of 0.87
- Inside Singapore’s growing healthy longevity market
- TSquared Health - Longevity Clinics
- NUS Medicine's Vincenzo Sorrentino joins EMBO Global Investigator Network
- Singapore’s longevity society: healthy ageing plans